Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Eggs | 9 | 2021 | 182 | 3.440 |
Why?
|
Fatty Acids, Nonesterified | 9 | 2023 | 394 | 2.350 |
Why?
|
Diet | 28 | 2024 | 8098 | 2.160 |
Why?
|
Heart Failure | 42 | 2024 | 11859 | 2.050 |
Why?
|
Fatty Acids, Omega-3 | 12 | 2024 | 1398 | 1.980 |
Why?
|
Nuts | 6 | 2021 | 265 | 1.940 |
Why?
|
Alcohol Drinking | 24 | 2011 | 4052 | 1.920 |
Why?
|
Veterans | 20 | 2024 | 2671 | 1.870 |
Why?
|
alpha-Linolenic Acid | 8 | 2014 | 144 | 1.870 |
Why?
|
Solanum tuberosum | 2 | 2024 | 47 | 1.780 |
Why?
|
Diabetes Mellitus, Type 2 | 28 | 2024 | 12242 | 1.490 |
Why?
|
Cardiovascular Diseases | 34 | 2024 | 15638 | 1.480 |
Why?
|
Cholesterol, Dietary | 6 | 2010 | 224 | 1.360 |
Why?
|
National Heart, Lung, and Blood Institute (U.S.) | 4 | 2023 | 325 | 1.350 |
Why?
|
Coronary Disease | 15 | 2021 | 5926 | 1.260 |
Why?
|
Physicians | 20 | 2022 | 4615 | 1.170 |
Why?
|
Fatty Acids, Monounsaturated | 6 | 2023 | 190 | 1.150 |
Why?
|
Fatty Acid-Binding Proteins | 3 | 2014 | 294 | 1.110 |
Why?
|
Risk Factors | 105 | 2024 | 74915 | 1.100 |
Why?
|
Coronary Artery Disease | 14 | 2023 | 6549 | 1.090 |
Why?
|
Proportional Hazards Models | 37 | 2024 | 12561 | 1.080 |
Why?
|
Oleic Acids | 3 | 2019 | 72 | 0.990 |
Why?
|
Aged | 151 | 2024 | 171514 | 0.980 |
Why?
|
Fatty Acids | 12 | 2023 | 1818 | 0.890 |
Why?
|
Veterans Health | 4 | 2021 | 215 | 0.880 |
Why?
|
Seafood | 5 | 2017 | 395 | 0.880 |
Why?
|
Prospective Studies | 65 | 2024 | 54913 | 0.870 |
Why?
|
Adiponectin | 6 | 2015 | 1118 | 0.840 |
Why?
|
Hypertension | 19 | 2022 | 8610 | 0.830 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 6 | 2023 | 3253 | 0.760 |
Why?
|
Aged, 80 and over | 72 | 2024 | 59679 | 0.740 |
Why?
|
Male | 181 | 2024 | 364761 | 0.730 |
Why?
|
Life Style | 14 | 2024 | 3929 | 0.710 |
Why?
|
United States | 74 | 2024 | 73120 | 0.710 |
Why?
|
Cohort Studies | 55 | 2024 | 41782 | 0.680 |
Why?
|
Risk Reduction Behavior | 4 | 2020 | 1120 | 0.670 |
Why?
|
Middle Aged | 120 | 2024 | 223406 | 0.650 |
Why?
|
Body Mass Index | 27 | 2022 | 13030 | 0.650 |
Why?
|
Feeding Behavior | 11 | 2015 | 3202 | 0.640 |
Why?
|
Incidence | 37 | 2024 | 21552 | 0.630 |
Why?
|
Apolipoproteins E | 4 | 2009 | 1461 | 0.620 |
Why?
|
Odds Ratio | 21 | 2019 | 9687 | 0.620 |
Why?
|
Humans | 225 | 2024 | 768369 | 0.620 |
Why?
|
Vegetables | 5 | 2015 | 1202 | 0.610 |
Why?
|
Phospholipids | 5 | 2015 | 783 | 0.580 |
Why?
|
Motor Activity | 3 | 2015 | 2722 | 0.580 |
Why?
|
Fruit | 4 | 2015 | 1165 | 0.570 |
Why?
|
Female | 159 | 2024 | 396926 | 0.570 |
Why?
|
Dietary Fats, Unsaturated | 5 | 2019 | 224 | 0.570 |
Why?
|
Diabetes Mellitus | 9 | 2021 | 5887 | 0.570 |
Why?
|
Huntington Disease | 7 | 2006 | 1145 | 0.560 |
Why?
|
Follow-Up Studies | 36 | 2022 | 39429 | 0.540 |
Why?
|
Fishes | 6 | 2021 | 605 | 0.540 |
Why?
|
Myocardial Infarction | 13 | 2022 | 11515 | 0.540 |
Why?
|
Cardiac Output, Low | 2 | 2007 | 191 | 0.530 |
Why?
|
Stroke Volume | 15 | 2024 | 5620 | 0.520 |
Why?
|
Health Behavior | 4 | 2015 | 2649 | 0.520 |
Why?
|
Risk Assessment | 25 | 2024 | 24310 | 0.510 |
Why?
|
Health Status | 8 | 2022 | 4096 | 0.510 |
Why?
|
Serum Albumin | 3 | 2003 | 676 | 0.490 |
Why?
|
Prevalence | 22 | 2021 | 15879 | 0.490 |
Why?
|
Atherosclerosis | 5 | 2022 | 3431 | 0.490 |
Why?
|
Eicosapentaenoic Acid | 3 | 2017 | 563 | 0.490 |
Why?
|
Catechin | 1 | 2015 | 70 | 0.490 |
Why?
|
Blood Pressure | 17 | 2022 | 8537 | 0.490 |
Why?
|
Procollagen | 5 | 2015 | 189 | 0.480 |
Why?
|
Fatty Acids, Unsaturated | 3 | 2023 | 542 | 0.470 |
Why?
|
Carotid Artery Diseases | 4 | 2015 | 879 | 0.470 |
Why?
|
Plasminogen Activator Inhibitor 1 | 3 | 2000 | 280 | 0.470 |
Why?
|
Women's Health | 3 | 2021 | 2079 | 0.460 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2016 | 125 | 0.460 |
Why?
|
Atrial Fibrillation | 8 | 2021 | 5162 | 0.460 |
Why?
|
Trinucleotide Repeats | 6 | 2006 | 257 | 0.450 |
Why?
|
Polymorphism, Genetic | 4 | 2007 | 4247 | 0.450 |
Why?
|
Linoleic Acid | 3 | 2005 | 159 | 0.450 |
Why?
|
Carotid Stenosis | 1 | 2021 | 864 | 0.450 |
Why?
|
Stroke | 12 | 2023 | 9790 | 0.450 |
Why?
|
Docosahexaenoic Acids | 4 | 2017 | 907 | 0.440 |
Why?
|
Adult | 82 | 2024 | 223528 | 0.440 |
Why?
|
Blood Glucose | 13 | 2019 | 6429 | 0.430 |
Why?
|
Ventricular Function, Left | 12 | 2024 | 3941 | 0.420 |
Why?
|
Diet, Mediterranean | 1 | 2019 | 747 | 0.410 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2007 | 330 | 0.410 |
Why?
|
Health | 2 | 2015 | 399 | 0.400 |
Why?
|
Plaque, Atherosclerotic | 1 | 2023 | 1547 | 0.380 |
Why?
|
Fish Oils | 1 | 2015 | 483 | 0.380 |
Why?
|
Cross-Sectional Studies | 28 | 2024 | 26348 | 0.380 |
Why?
|
Electrocardiography | 5 | 2016 | 6410 | 0.370 |
Why?
|
Erythrocyte Membrane | 1 | 2012 | 438 | 0.360 |
Why?
|
Family Health | 7 | 2008 | 1256 | 0.360 |
Why?
|
Confidence Intervals | 7 | 2017 | 2932 | 0.350 |
Why?
|
Bilirubin | 2 | 2003 | 439 | 0.350 |
Why?
|
Magnesium | 1 | 2013 | 816 | 0.340 |
Why?
|
Multivariate Analysis | 14 | 2018 | 12096 | 0.340 |
Why?
|
Cholesterol, HDL | 6 | 2009 | 1820 | 0.330 |
Why?
|
Angiotensinogen | 2 | 2007 | 160 | 0.330 |
Why?
|
Cacao | 1 | 2010 | 98 | 0.330 |
Why?
|
Men's Health | 2 | 2017 | 75 | 0.330 |
Why?
|
Sex Distribution | 8 | 2012 | 2286 | 0.320 |
Why?
|
Age Distribution | 7 | 2014 | 2881 | 0.310 |
Why?
|
Smoking | 17 | 2023 | 9099 | 0.310 |
Why?
|
Randomized Controlled Trials as Topic | 10 | 2019 | 10358 | 0.310 |
Why?
|
Heart Diseases | 5 | 2021 | 2816 | 0.300 |
Why?
|
Insulin | 10 | 2019 | 6606 | 0.300 |
Why?
|
Albuminuria | 3 | 2017 | 658 | 0.300 |
Why?
|
Cardiovascular System | 4 | 2024 | 838 | 0.300 |
Why?
|
Mobility Limitation | 2 | 2023 | 409 | 0.300 |
Why?
|
Cystatins | 1 | 2007 | 55 | 0.290 |
Why?
|
Trans Fatty Acids | 2 | 2022 | 155 | 0.290 |
Why?
|
United States Department of Veterans Affairs | 7 | 2024 | 937 | 0.290 |
Why?
|
Glomerular Filtration Rate | 7 | 2022 | 2226 | 0.290 |
Why?
|
Alcoholic Beverages | 3 | 2004 | 266 | 0.290 |
Why?
|
Self Report | 7 | 2024 | 3771 | 0.290 |
Why?
|
Brain Ischemia | 4 | 2012 | 3038 | 0.290 |
Why?
|
Body Height | 1 | 2013 | 1568 | 0.280 |
Why?
|
Mississippi | 3 | 2018 | 94 | 0.280 |
Why?
|
Flavonoids | 1 | 2010 | 447 | 0.280 |
Why?
|
Lysine | 3 | 2019 | 990 | 0.280 |
Why?
|
Obesity | 9 | 2022 | 13065 | 0.280 |
Why?
|
Adiposity | 2 | 2019 | 1888 | 0.270 |
Why?
|
Fucosyltransferases | 1 | 2007 | 118 | 0.270 |
Why?
|
Down Syndrome | 1 | 2015 | 914 | 0.270 |
Why?
|
Hypertrophy, Left Ventricular | 2 | 2012 | 857 | 0.270 |
Why?
|
Genome-Wide Association Study | 12 | 2024 | 12771 | 0.260 |
Why?
|
Peripheral Arterial Disease | 4 | 2023 | 1299 | 0.260 |
Why?
|
INDEL Mutation | 1 | 2007 | 267 | 0.260 |
Why?
|
Chromosomes, Human, Pair 4 | 2 | 2004 | 375 | 0.260 |
Why?
|
Frail Elderly | 4 | 2024 | 774 | 0.260 |
Why?
|
Linolenic Acids | 1 | 2005 | 7 | 0.260 |
Why?
|
Peptide Fragments | 8 | 2022 | 5151 | 0.260 |
Why?
|
Dietary Fats | 5 | 2012 | 2003 | 0.250 |
Why?
|
Dietary Fiber | 4 | 2007 | 767 | 0.250 |
Why?
|
Dairy Products | 2 | 2006 | 490 | 0.250 |
Why?
|
Hospitalization | 9 | 2024 | 10845 | 0.250 |
Why?
|
Risk | 8 | 2017 | 9642 | 0.250 |
Why?
|
Sodium | 3 | 2022 | 1595 | 0.250 |
Why?
|
Atrial Natriuretic Factor | 1 | 2006 | 350 | 0.250 |
Why?
|
Lipogenesis | 2 | 2020 | 216 | 0.250 |
Why?
|
Alcohol Dehydrogenase | 1 | 2005 | 113 | 0.240 |
Why?
|
Behavioral Risk Factor Surveillance System | 1 | 2006 | 211 | 0.240 |
Why?
|
Mendelian Randomization Analysis | 5 | 2024 | 1036 | 0.240 |
Why?
|
Ventricular Dysfunction, Left | 4 | 2022 | 2145 | 0.240 |
Why?
|
Health Surveys | 3 | 2021 | 4056 | 0.240 |
Why?
|
Transforming Growth Factor beta | 4 | 2017 | 2003 | 0.230 |
Why?
|
Genetic Loci | 5 | 2015 | 2630 | 0.230 |
Why?
|
Genetic Linkage | 5 | 2006 | 2342 | 0.230 |
Why?
|
gamma-Linolenic Acid | 1 | 2003 | 16 | 0.230 |
Why?
|
National Institutes of Health (U.S.) | 6 | 2004 | 794 | 0.230 |
Why?
|
Cardiomyopathies | 3 | 2023 | 2056 | 0.220 |
Why?
|
Case-Control Studies | 11 | 2015 | 22286 | 0.220 |
Why?
|
Death, Sudden, Cardiac | 1 | 2012 | 1568 | 0.220 |
Why?
|
Alleles | 8 | 2016 | 6880 | 0.220 |
Why?
|
Logistic Models | 8 | 2013 | 13323 | 0.220 |
Why?
|
Wine | 2 | 2004 | 172 | 0.210 |
Why?
|
Receptors, Transferrin | 1 | 2024 | 300 | 0.210 |
Why?
|
Cholesterol, LDL | 6 | 2005 | 2396 | 0.210 |
Why?
|
Cause of Death | 5 | 2024 | 3727 | 0.210 |
Why?
|
Polymorphism, Single Nucleotide | 14 | 2024 | 16023 | 0.210 |
Why?
|
Tachycardia, Ventricular | 2 | 2016 | 1309 | 0.200 |
Why?
|
Aging | 5 | 2015 | 8762 | 0.200 |
Why?
|
Food | 2 | 2024 | 770 | 0.200 |
Why?
|
Hypoalbuminemia | 1 | 2003 | 90 | 0.200 |
Why?
|
Nutrition Surveys | 3 | 2006 | 1734 | 0.200 |
Why?
|
Mitochondria | 1 | 2015 | 3672 | 0.190 |
Why?
|
Prognosis | 15 | 2023 | 30031 | 0.190 |
Why?
|
Exercise | 7 | 2023 | 5940 | 0.190 |
Why?
|
Geriatric Assessment | 4 | 2024 | 1422 | 0.190 |
Why?
|
Birth Weight | 2 | 2020 | 2117 | 0.190 |
Why?
|
Meat | 1 | 2024 | 586 | 0.190 |
Why?
|
Time Factors | 14 | 2024 | 40271 | 0.190 |
Why?
|
Intermediate Filaments | 1 | 2021 | 171 | 0.190 |
Why?
|
Creatinine | 4 | 2021 | 1915 | 0.180 |
Why?
|
Linear Models | 7 | 2021 | 5880 | 0.180 |
Why?
|
Spironolactone | 1 | 2024 | 412 | 0.180 |
Why?
|
Triglycerides | 4 | 2005 | 2465 | 0.180 |
Why?
|
Hypercholesterolemia | 2 | 2008 | 1142 | 0.180 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2022 | 2279 | 0.170 |
Why?
|
Ceramides | 1 | 2021 | 203 | 0.170 |
Why?
|
Heart Rate | 5 | 2020 | 4218 | 0.170 |
Why?
|
Lipids | 4 | 2018 | 3346 | 0.170 |
Why?
|
Sex Characteristics | 2 | 2008 | 2667 | 0.170 |
Why?
|
Sleep | 2 | 2022 | 4796 | 0.170 |
Why?
|
Heart Conduction System | 1 | 2005 | 1009 | 0.170 |
Why?
|
Genotype | 13 | 2016 | 13045 | 0.170 |
Why?
|
Independent Living | 4 | 2021 | 580 | 0.170 |
Why?
|
Aspirin | 4 | 2022 | 3139 | 0.160 |
Why?
|
Nitroglycerin | 2 | 2016 | 332 | 0.160 |
Why?
|
Age Factors | 9 | 2021 | 18477 | 0.160 |
Why?
|
Puerperal Disorders | 1 | 2022 | 303 | 0.160 |
Why?
|
Homeostasis | 2 | 2024 | 3351 | 0.160 |
Why?
|
Mortality | 4 | 2023 | 2917 | 0.160 |
Why?
|
Sex Factors | 8 | 2021 | 10647 | 0.160 |
Why?
|
Age of Onset | 8 | 2013 | 3342 | 0.160 |
Why?
|
Gait | 1 | 2024 | 822 | 0.150 |
Why?
|
Body Size | 1 | 2021 | 463 | 0.150 |
Why?
|
Sodium, Dietary | 1 | 2022 | 427 | 0.150 |
Why?
|
Muscular Atrophy | 1 | 2021 | 335 | 0.150 |
Why?
|
Intermittent Claudication | 1 | 2000 | 305 | 0.150 |
Why?
|
Chromosomes, Human, Pair 18 | 3 | 2004 | 247 | 0.150 |
Why?
|
American Heart Association | 2 | 2020 | 1049 | 0.150 |
Why?
|
Coronary Vessels | 5 | 2023 | 3123 | 0.150 |
Why?
|
Sulfonamides | 2 | 2019 | 1988 | 0.150 |
Why?
|
Ventricular Dysfunction, Right | 1 | 2023 | 645 | 0.150 |
Why?
|
Nutritional Status | 2 | 2024 | 1623 | 0.150 |
Why?
|
Longitudinal Studies | 10 | 2021 | 14766 | 0.150 |
Why?
|
Disabled Persons | 2 | 2020 | 1218 | 0.140 |
Why?
|
Nutrition Assessment | 2 | 2015 | 740 | 0.140 |
Why?
|
Calcinosis | 2 | 2006 | 1484 | 0.140 |
Why?
|
Cholesterol | 3 | 2019 | 2910 | 0.140 |
Why?
|
Cooking | 1 | 2019 | 311 | 0.140 |
Why?
|
Diet Surveys | 3 | 2024 | 1161 | 0.140 |
Why?
|
Energy Intake | 4 | 2024 | 2141 | 0.130 |
Why?
|
Comorbidity | 7 | 2021 | 10601 | 0.130 |
Why?
|
Dietary Supplements | 4 | 2022 | 3445 | 0.130 |
Why?
|
Patient Compliance | 2 | 2018 | 2696 | 0.130 |
Why?
|
Retrospective Studies | 15 | 2024 | 81835 | 0.130 |
Why?
|
Iron | 1 | 2024 | 1813 | 0.130 |
Why?
|
Massachusetts | 6 | 2004 | 8905 | 0.130 |
Why?
|
Apolipoprotein E4 | 3 | 2009 | 712 | 0.130 |
Why?
|
Alcoholism | 2 | 2004 | 1993 | 0.130 |
Why?
|
Double-Blind Method | 3 | 2019 | 12450 | 0.130 |
Why?
|
Hypotension | 1 | 2021 | 888 | 0.130 |
Why?
|
Receptors, Cytokine | 1 | 2016 | 257 | 0.120 |
Why?
|
Pyrimidines | 2 | 2019 | 3050 | 0.120 |
Why?
|
C-Reactive Protein | 4 | 2014 | 3854 | 0.120 |
Why?
|
Lung Neoplasms | 2 | 2014 | 13589 | 0.120 |
Why?
|
Electric Countershock | 1 | 2018 | 534 | 0.120 |
Why?
|
Preventive Health Services | 1 | 2020 | 568 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 8 | 2020 | 18047 | 0.120 |
Why?
|
Fibrinogen | 1 | 1998 | 893 | 0.120 |
Why?
|
Insulin Resistance | 6 | 2019 | 3974 | 0.120 |
Why?
|
Bone Remodeling | 1 | 2018 | 583 | 0.120 |
Why?
|
Survival Rate | 4 | 2014 | 12875 | 0.120 |
Why?
|
Homeodomain Proteins | 1 | 2004 | 2431 | 0.120 |
Why?
|
Nutrigenomics | 1 | 2013 | 24 | 0.110 |
Why?
|
Chromatography, Gas | 1 | 2014 | 150 | 0.110 |
Why?
|
Ethanol | 3 | 2009 | 1334 | 0.110 |
Why?
|
Molecular Weight | 2 | 2012 | 2173 | 0.110 |
Why?
|
Thrombosis | 2 | 2007 | 2954 | 0.110 |
Why?
|
Fasting | 3 | 2010 | 1608 | 0.110 |
Why?
|
Chi-Square Distribution | 3 | 2013 | 3438 | 0.110 |
Why?
|
Data Mining | 1 | 2018 | 561 | 0.110 |
Why?
|
Epistasis, Genetic | 1 | 2015 | 352 | 0.110 |
Why?
|
Health Status Indicators | 1 | 2018 | 971 | 0.100 |
Why?
|
Fatty Acids, Omega-6 | 1 | 2014 | 225 | 0.100 |
Why?
|
Metabolic Diseases | 2 | 2019 | 685 | 0.100 |
Why?
|
Angina Pectoris | 1 | 2016 | 960 | 0.100 |
Why?
|
Ankle Brachial Index | 3 | 2023 | 163 | 0.100 |
Why?
|
Propensity Score | 1 | 2020 | 1970 | 0.100 |
Why?
|
Carcinoma, Renal Cell | 2 | 2019 | 3198 | 0.100 |
Why?
|
Chromosomes, Human, Pair 6 | 3 | 2014 | 370 | 0.100 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 3 | 2014 | 3813 | 0.100 |
Why?
|
Urinary Bladder Neoplasms | 1 | 2004 | 2254 | 0.100 |
Why?
|
Body Composition | 1 | 2021 | 2455 | 0.100 |
Why?
|
Peripartum Period | 2 | 2023 | 138 | 0.100 |
Why?
|
Renal Insufficiency, Chronic | 2 | 2017 | 2291 | 0.100 |
Why?
|
Glucose | 1 | 2023 | 4355 | 0.090 |
Why?
|
Exercise Tolerance | 1 | 2016 | 849 | 0.090 |
Why?
|
Reproducibility of Results | 5 | 2024 | 20232 | 0.090 |
Why?
|
Weight Loss | 1 | 2002 | 2710 | 0.090 |
Why?
|
Lod Score | 4 | 2004 | 600 | 0.090 |
Why?
|
Genetic Variation | 7 | 2019 | 6607 | 0.090 |
Why?
|
Body Constitution | 2 | 2003 | 273 | 0.090 |
Why?
|
Gene Frequency | 3 | 2012 | 3615 | 0.090 |
Why?
|
Shock, Cardiogenic | 1 | 2016 | 711 | 0.090 |
Why?
|
Chromosomes, Human, Pair 1 | 2 | 2004 | 640 | 0.090 |
Why?
|
Body Fat Distribution | 1 | 2011 | 245 | 0.090 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2014 | 635 | 0.090 |
Why?
|
Probability | 2 | 2007 | 2483 | 0.090 |
Why?
|
Equipment Failure | 1 | 2012 | 585 | 0.090 |
Why?
|
Activities of Daily Living | 2 | 2023 | 2433 | 0.090 |
Why?
|
Basic Helix-Loop-Helix Transcription Factors | 1 | 2016 | 1143 | 0.080 |
Why?
|
Fats | 1 | 2010 | 99 | 0.080 |
Why?
|
Diabetic Angiopathies | 1 | 2015 | 806 | 0.080 |
Why?
|
Syncope | 1 | 2012 | 430 | 0.080 |
Why?
|
Regression Analysis | 4 | 2010 | 6353 | 0.080 |
Why?
|
Reference Values | 2 | 2007 | 4941 | 0.080 |
Why?
|
Angiogenesis Inhibitors | 1 | 2019 | 2062 | 0.080 |
Why?
|
Genetic Markers | 4 | 2009 | 2604 | 0.080 |
Why?
|
Retinal Diseases | 1 | 2015 | 711 | 0.080 |
Why?
|
Cardiomyopathy, Alcoholic | 1 | 2008 | 6 | 0.080 |
Why?
|
Epidemiologic Methods | 2 | 2015 | 1337 | 0.080 |
Why?
|
Defibrillators, Implantable | 1 | 2018 | 1498 | 0.080 |
Why?
|
Arrhythmias, Cardiac | 1 | 2018 | 2258 | 0.080 |
Why?
|
Quality Indicators, Health Care | 1 | 2018 | 1813 | 0.070 |
Why?
|
Acetaminophen | 2 | 2022 | 556 | 0.070 |
Why?
|
Medicare | 2 | 2022 | 6880 | 0.070 |
Why?
|
Genome, Human | 6 | 2006 | 4454 | 0.070 |
Why?
|
Waist Circumference | 1 | 2011 | 935 | 0.070 |
Why?
|
Nonlinear Dynamics | 1 | 2010 | 496 | 0.070 |
Why?
|
Temperance | 1 | 2007 | 88 | 0.070 |
Why?
|
Fibrosis | 4 | 2015 | 2076 | 0.070 |
Why?
|
Endothelium, Vascular | 1 | 1999 | 4426 | 0.070 |
Why?
|
Diuretics | 2 | 2022 | 612 | 0.070 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2017 | 1252 | 0.070 |
Why?
|
Intracranial Hemorrhages | 1 | 2012 | 815 | 0.070 |
Why?
|
Pacemaker, Artificial | 1 | 2012 | 828 | 0.070 |
Why?
|
Pharmaceutical Preparations | 1 | 2015 | 1089 | 0.070 |
Why?
|
Pilot Projects | 2 | 2012 | 8730 | 0.070 |
Why?
|
Receptors, Kainic Acid | 1 | 2006 | 91 | 0.070 |
Why?
|
Pedigree | 4 | 2008 | 4545 | 0.070 |
Why?
|
Causality | 1 | 2012 | 1255 | 0.070 |
Why?
|
Cystatin C | 1 | 2007 | 272 | 0.070 |
Why?
|
Indazoles | 2 | 2019 | 306 | 0.060 |
Why?
|
Vitamin D | 1 | 2019 | 3311 | 0.060 |
Why?
|
Obesity, Morbid | 1 | 2017 | 1309 | 0.060 |
Why?
|
Natriuretic Peptide, Brain | 3 | 2022 | 1751 | 0.060 |
Why?
|
Radioimmunoassay | 1 | 2006 | 862 | 0.060 |
Why?
|
Brachial Artery | 2 | 2015 | 374 | 0.060 |
Why?
|
Urinalysis | 1 | 2008 | 369 | 0.060 |
Why?
|
Residence Characteristics | 2 | 2012 | 2119 | 0.060 |
Why?
|
Kidney Function Tests | 1 | 2007 | 681 | 0.060 |
Why?
|
Educational Status | 2 | 2003 | 2519 | 0.060 |
Why?
|
Glycemic Index | 1 | 2007 | 400 | 0.060 |
Why?
|
Patient Admission | 1 | 2012 | 1370 | 0.060 |
Why?
|
Adolescent | 9 | 2022 | 89163 | 0.060 |
Why?
|
Poultry | 1 | 2024 | 80 | 0.060 |
Why?
|
MSX1 Transcription Factor | 1 | 2004 | 53 | 0.060 |
Why?
|
Beer | 1 | 2004 | 135 | 0.060 |
Why?
|
Electronic Health Records | 2 | 2020 | 4877 | 0.060 |
Why?
|
3' Untranslated Regions | 1 | 2006 | 514 | 0.060 |
Why?
|
Quantitative Trait Loci | 3 | 2012 | 2126 | 0.060 |
Why?
|
Transcription Factors | 1 | 2004 | 12176 | 0.060 |
Why?
|
Predictive Value of Tests | 3 | 2015 | 15459 | 0.060 |
Why?
|
Stearic Acids | 2 | 2014 | 56 | 0.060 |
Why?
|
Hyperglycemia | 1 | 2012 | 1389 | 0.050 |
Why?
|
Epidemiologic Studies | 1 | 2007 | 681 | 0.050 |
Why?
|
Animals | 8 | 2024 | 169424 | 0.050 |
Why?
|
Calcium, Dietary | 1 | 2006 | 533 | 0.050 |
Why?
|
Liver | 1 | 2019 | 7575 | 0.050 |
Why?
|
Palmitic Acid | 2 | 2014 | 149 | 0.050 |
Why?
|
Models, Genetic | 4 | 2006 | 3442 | 0.050 |
Why?
|
Treatment Outcome | 8 | 2024 | 65408 | 0.050 |
Why?
|
Stress, Psychological | 1 | 2018 | 4538 | 0.050 |
Why?
|
Calcium | 1 | 2015 | 5793 | 0.050 |
Why?
|
Antihypertensive Agents | 2 | 2014 | 2028 | 0.050 |
Why?
|
Diet Records | 1 | 2024 | 427 | 0.050 |
Why?
|
Morbidity | 1 | 2007 | 1760 | 0.050 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2024 | 560 | 0.050 |
Why?
|
Metabolic Networks and Pathways | 2 | 2020 | 797 | 0.050 |
Why?
|
Coronary Angiography | 1 | 2013 | 4526 | 0.050 |
Why?
|
Erythrocytes | 1 | 2011 | 2422 | 0.050 |
Why?
|
DNA Methylation | 1 | 2016 | 4425 | 0.050 |
Why?
|
Quantitative Trait, Heritable | 2 | 2005 | 540 | 0.050 |
Why?
|
Echocardiography | 2 | 2018 | 5043 | 0.050 |
Why?
|
Socioeconomic Factors | 1 | 2015 | 7863 | 0.050 |
Why?
|
Hyperlipidemia, Familial Combined | 1 | 2000 | 14 | 0.050 |
Why?
|
DNA Mutational Analysis | 1 | 2009 | 4120 | 0.050 |
Why?
|
Time | 1 | 2002 | 546 | 0.050 |
Why?
|
Carotid Arteries | 2 | 2002 | 943 | 0.040 |
Why?
|
Body Weight | 1 | 2011 | 4630 | 0.040 |
Why?
|
Ultrasonography | 3 | 2003 | 5994 | 0.040 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2005 | 10784 | 0.040 |
Why?
|
Disease Progression | 4 | 2021 | 13643 | 0.040 |
Why?
|
Aortic Diseases | 1 | 2006 | 742 | 0.040 |
Why?
|
Chromosomes, Human, Pair 5 | 2 | 2016 | 387 | 0.040 |
Why?
|
New England | 1 | 2003 | 1056 | 0.040 |
Why?
|
Stress Disorders, Post-Traumatic | 1 | 2018 | 4636 | 0.040 |
Why?
|
Chromosome Segregation | 1 | 2001 | 236 | 0.040 |
Why?
|
Echocardiography, Doppler, Pulsed | 1 | 1999 | 69 | 0.040 |
Why?
|
Smoking Cessation | 1 | 2011 | 2078 | 0.040 |
Why?
|
Marital Status | 1 | 2021 | 426 | 0.040 |
Why?
|
Kidney Neoplasms | 1 | 2016 | 4299 | 0.040 |
Why?
|
Neurofilament Proteins | 1 | 2021 | 337 | 0.040 |
Why?
|
Analysis of Variance | 3 | 2005 | 6242 | 0.040 |
Why?
|
Haplotypes | 1 | 2005 | 2723 | 0.040 |
Why?
|
Fibrinolysis | 1 | 2000 | 333 | 0.040 |
Why?
|
Genetic Testing | 2 | 2009 | 3586 | 0.040 |
Why?
|
Hand Strength | 1 | 2021 | 465 | 0.040 |
Why?
|
Databases, Factual | 3 | 2018 | 8081 | 0.040 |
Why?
|
Albumins | 2 | 2014 | 578 | 0.040 |
Why?
|
Respiratory Function Tests | 1 | 2003 | 1697 | 0.040 |
Why?
|
Osteocalcin | 1 | 2018 | 277 | 0.040 |
Why?
|
Linkage Disequilibrium | 2 | 2013 | 1998 | 0.040 |
Why?
|
Young Adult | 4 | 2019 | 60038 | 0.040 |
Why?
|
Drug Synergism | 1 | 2001 | 1765 | 0.040 |
Why?
|
Cholecalciferol | 1 | 2022 | 557 | 0.040 |
Why?
|
Protein Isoforms | 1 | 2002 | 1706 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2016 | 15965 | 0.040 |
Why?
|
Skull | 1 | 2021 | 832 | 0.040 |
Why?
|
Chronic Disease | 2 | 2016 | 9379 | 0.030 |
Why?
|
Life Expectancy | 1 | 2023 | 1249 | 0.030 |
Why?
|
Tomography, X-Ray Computed | 2 | 2013 | 20763 | 0.030 |
Why?
|
Vascular Resistance | 1 | 1999 | 941 | 0.030 |
Why?
|
Europe | 2 | 2017 | 3439 | 0.030 |
Why?
|
Blood Flow Velocity | 1 | 1999 | 1377 | 0.030 |
Why?
|
Infant, Low Birth Weight | 1 | 2020 | 875 | 0.030 |
Why?
|
Absorptiometry, Photon | 1 | 2021 | 1749 | 0.030 |
Why?
|
Forced Expiratory Volume | 1 | 2000 | 1820 | 0.030 |
Why?
|
Vasodilator Agents | 1 | 1999 | 991 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2012 | 14725 | 0.030 |
Why?
|
Eicosanoic Acids | 1 | 2014 | 15 | 0.030 |
Why?
|
Collagen Type I | 1 | 2018 | 620 | 0.030 |
Why?
|
Quality of Life | 1 | 2016 | 13497 | 0.030 |
Why?
|
Antigens | 1 | 2000 | 1443 | 0.030 |
Why?
|
Hyperlipoproteinemia Type II | 1 | 1999 | 398 | 0.030 |
Why?
|
Computer Communication Networks | 1 | 2016 | 295 | 0.030 |
Why?
|
Bone Resorption | 1 | 2018 | 727 | 0.030 |
Why?
|
Adrenergic beta-Antagonists | 1 | 2020 | 1244 | 0.030 |
Why?
|
Niacinamide | 1 | 2016 | 419 | 0.030 |
Why?
|
Fatty Acid Desaturases | 1 | 2014 | 102 | 0.030 |
Why?
|
Vitamins | 1 | 2022 | 1638 | 0.030 |
Why?
|
Child | 5 | 2006 | 80856 | 0.030 |
Why?
|
Uric Acid | 1 | 2000 | 808 | 0.030 |
Why?
|
Chromosomes, Human, Pair 10 | 1 | 2014 | 277 | 0.030 |
Why?
|
Gene Expression Regulation | 2 | 2016 | 11928 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2016 | 13709 | 0.030 |
Why?
|
Cross-Over Studies | 1 | 1999 | 2103 | 0.030 |
Why?
|
Phenylurea Compounds | 1 | 2016 | 532 | 0.030 |
Why?
|
Genomics | 2 | 2022 | 5912 | 0.030 |
Why?
|
Life Change Events | 1 | 2018 | 964 | 0.030 |
Why?
|
Oleic Acid | 1 | 2013 | 92 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2014 | 344 | 0.030 |
Why?
|
Recurrence | 2 | 2016 | 8510 | 0.030 |
Why?
|
International Classification of Diseases | 1 | 2018 | 925 | 0.030 |
Why?
|
Menopause | 1 | 2000 | 1650 | 0.020 |
Why?
|
Osteoporotic Fractures | 1 | 2017 | 417 | 0.020 |
Why?
|
Chromosomes, Human, Pair 2 | 1 | 2013 | 313 | 0.020 |
Why?
|
Recovery of Function | 1 | 2022 | 2994 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2016 | 1609 | 0.020 |
Why?
|
Plant Oils | 1 | 2012 | 199 | 0.020 |
Why?
|
Pregnancy | 2 | 2023 | 30179 | 0.020 |
Why?
|
Vasodilation | 1 | 2015 | 968 | 0.020 |
Why?
|
Immunoassay | 1 | 2014 | 746 | 0.020 |
Why?
|
Israel | 1 | 2012 | 726 | 0.020 |
Why?
|
Lung Diseases | 1 | 2000 | 1926 | 0.020 |
Why?
|
Pyrroles | 1 | 2016 | 1127 | 0.020 |
Why?
|
Income | 1 | 1998 | 1878 | 0.020 |
Why?
|
Echocardiography, Doppler | 1 | 2013 | 899 | 0.020 |
Why?
|
Infant, Newborn | 2 | 2020 | 26394 | 0.020 |
Why?
|
Natural Language Processing | 1 | 2018 | 1197 | 0.020 |
Why?
|
Nuclear Family | 2 | 2000 | 311 | 0.020 |
Why?
|
Phenotype | 5 | 2006 | 16712 | 0.020 |
Why?
|
Diabetes Complications | 1 | 2015 | 1322 | 0.020 |
Why?
|
Spirometry | 2 | 2003 | 928 | 0.020 |
Why?
|
Indoles | 1 | 2016 | 1834 | 0.020 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2003 | 3246 | 0.020 |
Why?
|
Organ Size | 1 | 2013 | 2268 | 0.020 |
Why?
|
Bone and Bones | 1 | 2018 | 2589 | 0.020 |
Why?
|
Mental Health | 1 | 2022 | 3271 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2021 | 3804 | 0.020 |
Why?
|
Venezuela | 1 | 2006 | 73 | 0.020 |
Why?
|
Vitamin E | 1 | 2011 | 873 | 0.020 |
Why?
|
Heart Atria | 1 | 2013 | 1361 | 0.020 |
Why?
|
HEK293 Cells | 1 | 2016 | 4294 | 0.020 |
Why?
|
Muscle, Skeletal | 1 | 2021 | 4984 | 0.020 |
Why?
|
Pain Measurement | 1 | 2016 | 3577 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4132 | 0.020 |
Why?
|
Venous Thromboembolism | 1 | 2019 | 1881 | 0.020 |
Why?
|
Models, Statistical | 1 | 2020 | 5103 | 0.020 |
Why?
|
Databases, Genetic | 1 | 2012 | 1754 | 0.020 |
Why?
|
Lung | 1 | 2024 | 10090 | 0.020 |
Why?
|
Kidney | 1 | 2021 | 7064 | 0.020 |
Why?
|
Cytosine | 1 | 2006 | 213 | 0.020 |
Why?
|
Guanine | 1 | 2006 | 279 | 0.020 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2016 | 3520 | 0.020 |
Why?
|
Trinucleotide Repeat Expansion | 1 | 2006 | 254 | 0.020 |
Why?
|
Adenocarcinoma | 1 | 2002 | 6400 | 0.020 |
Why?
|
Combined Modality Therapy | 1 | 2016 | 8559 | 0.010 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2005 | 350 | 0.010 |
Why?
|
Child, Preschool | 2 | 2005 | 42620 | 0.010 |
Why?
|
Quality of Health Care | 1 | 2019 | 4340 | 0.010 |
Why?
|
Health Knowledge, Attitudes, Practice | 1 | 2018 | 4049 | 0.010 |
Why?
|
North America | 1 | 2006 | 1292 | 0.010 |
Why?
|
Australia | 1 | 2006 | 1264 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4774 | 0.010 |
Why?
|
Delivery of Health Care | 1 | 2021 | 5367 | 0.010 |
Why?
|
Oxidative Stress | 1 | 2014 | 3145 | 0.010 |
Why?
|
Dietary Carbohydrates | 1 | 2007 | 896 | 0.010 |
Why?
|
Kidney Failure, Chronic | 1 | 2015 | 2489 | 0.010 |
Why?
|
Aorta, Abdominal | 1 | 2005 | 627 | 0.010 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2005 | 792 | 0.010 |
Why?
|
Inflammation | 1 | 2021 | 10863 | 0.010 |
Why?
|
Markov Chains | 1 | 2005 | 977 | 0.010 |
Why?
|
Multicenter Studies as Topic | 1 | 2006 | 1727 | 0.010 |
Why?
|
Apolipoproteins C | 1 | 2000 | 59 | 0.010 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6537 | 0.010 |
Why?
|
Heart Ventricles | 1 | 2013 | 3839 | 0.010 |
Why?
|
Adenine | 1 | 2006 | 993 | 0.010 |
Why?
|
Blood Vessels | 1 | 2006 | 1112 | 0.010 |
Why?
|
Exons | 1 | 2006 | 2392 | 0.010 |
Why?
|
Apolipoproteins A | 1 | 2000 | 96 | 0.010 |
Why?
|
Family | 2 | 2001 | 3208 | 0.010 |
Why?
|
Apolipoprotein A-I | 1 | 2000 | 305 | 0.010 |
Why?
|
Apolipoprotein C-III | 1 | 2000 | 210 | 0.010 |
Why?
|
Cluster Analysis | 1 | 2005 | 2730 | 0.010 |
Why?
|
Parents | 2 | 2005 | 3596 | 0.010 |
Why?
|
Systole | 1 | 2000 | 938 | 0.010 |
Why?
|
Diastole | 1 | 2000 | 784 | 0.010 |
Why?
|
Vital Capacity | 1 | 2000 | 984 | 0.010 |
Why?
|
Long QT Syndrome | 1 | 2001 | 472 | 0.010 |
Why?
|
Posture | 1 | 2000 | 956 | 0.010 |
Why?
|
Genetics, Population | 1 | 2001 | 946 | 0.010 |
Why?
|
Mutation | 1 | 2000 | 30235 | 0.010 |
Why?
|
Arteriosclerosis | 1 | 2000 | 1056 | 0.010 |
Why?
|
Anthropometry | 1 | 2000 | 1343 | 0.010 |
Why?
|
Genome | 1 | 2003 | 1750 | 0.010 |
Why?
|
Chromosome Mapping | 1 | 2003 | 4622 | 0.010 |
Why?
|
Magnetic Resonance Imaging | 1 | 2021 | 36840 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2000 | 2362 | 0.010 |
Why?
|